HCPLive Network
Latest Managed Care Headlines
Thursday, December 18, 2014
By Laura Joszt
In the next several weeks more than 257,000 physicians and other healthcare providers will receive notification that 1% of their pay next year will be penalized for failing to meet meaningful use, CMS announced Wednesday.
Thursday, December 18, 2014
Superspreaders, who account for roughly 20% of the population, are more contagious than others and transmit about 80% of certain diseases, The Wall Street Journal reports.
Thursday, December 18, 2014
The FDA offered up an early retrospective of the 2014 year of approvals Friday with a rundown the regulator feels pretty good about.
Thursday, December 18, 2014
By Laura Joszt
While this year’s flu season is expected to be severe, the vaccine is a relatively poor match for current flu strains.
Wednesday, December 17, 2014
By Laura Joszt
Although just 15% of the US population is enrolled in a consumer-driven health plan, these individuals are more involved in their healthcare, according to a new report from the Employee Benefit Research Institute.
Wednesday, December 17, 2014
By Laura Joszt
States designing and testing healthcare payment and service delivery models to improve quality of care and lower costs will be receiving more than $665 million in funding from the government, according to HHS Secretary Sylvia M. Burwell.
Wednesday, December 17, 2014
How do ACOs reach the point of delivering both savings and better care? The recent online session of the ACO and Emerging Healthcare Delivery Coalition, sponsored by The American Journal of Managed Care, covered how ACOs evolve, how that process applies to oncology care, and how managed care can benefit from a better model for mental health delivery.
Tuesday, December 16, 2014
The American Society of Clinical Oncology called for greater access to and education about phase I clinical trials, the first-in-human studies of new agents designed to fight cancer.
Tuesday, December 16, 2014
The approval was based on the results of a clinical trial that demonstrated improved PFS in patients on lanreotide. While the median PFS in the placebo arm was 16 months, patients in the lanreotide arm had not yet reached median PFS at the time of analysis, and it was anticipated to extend beyond 22 months.
Tuesday, December 16, 2014
By Steven R. Peskin, MD, MBA; and Germin G. Fahim, PharmD, BCPS
The intended audience for this activity consists of medical directors, pharmacy directors, pharmacy benefit managers, and other managed care professionals who are involved with the treatment of patients with acute coronary syndrome.
Physician's Money Digest
Retiree optimism is up significantly in the fourth quarter, but investors remain more circumspect.
At times, every hospital feels like the busiest hospital in the country. Inpatient, outpatient, and emergency cases crisscross the hallways as nurses and doctors run past one another. Which hospitals, though, are actually the busiest in the nation?